Effect of transforming growth factor β on experimental Salmonella typhimurium infection in mice

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1432-1438

  Galdiero, Massimiliano ^a   Marcatili, Antonella ^b   Cipollaro De L'Ero, Gabriella ^b   Nuzzo, Immacolata ^b   Bentivoglio, Concetta ^b   Galdiero, Marilena ^b   Carratelli, Caterina Romano ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOKINE; HEAT SHOCK PROTEIN 60; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN CELL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0033050552     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1432-1438.1999     Document Type: Article

References (43)

1. Ahuja, S. S., F. Paliogianni, Y. Hidehiro, J. E. Balow, and D. T. Boumpas. 1993. Effect of transforming growth factor-β on early and late activation events in human T cells. J. Immunol. 150:3109-3118.
2. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madres, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020-6024.
3. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1114-1119.
4. Barral, A., M. Barral-Netto, E. C. Young, E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming factor-β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90:3442-3446.
5. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
6. Barton, B. E., and J. V. Jackson. 1993. Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61: 1496-1499.
7. Boog, E. R., E. R. de Graeff-Meeder, M. A. Lucassen, R. van der Zee, M. M. Voorhorst-Ogink, P. J. van Kooten, H. J. Geuze, and W. Van Eden. 1992. Two monoclonal antibodies generated against human HSP60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J. Exp. Med. 175:1805-1810.
8. Bucklin, S. E., R. Silverstein, and D. C. Morrison. 1993. An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality. Infect. Immun. 61:3184-3189.
9. Buttke, T. M. 1984. Inhibition of lymphocyte proliferation by free fatty acids. Immunology 53:5-42.
10. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffella, P. Puccelti, and F. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23: 1034-1038.
11. Chantry, D., M. Turner, E. Abney, and M. Feldman. 1989. Modulation of cytokine production by TGF-β. J. Immunol. 142:4295-4300.
12. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
13. Croft, M., L. Carter, S. Swain, and R. W. Dulton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715-1728.
14. Czariecki, C. W., H. H. Chiu, G. H. W. Wong, S. M. McCabe, and M. A. Palladino. 1988. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:4217-4223.
15. 1 down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. J. Cell. Physiol. 147:460-469.
16. 1) plays a detrimental role in the progression of experimental Mycobacterium avium infection: in vivo and in vitro evidence. Microb. Pathog. 11:367-372.
17. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
18. Ellner, J. J. 1978. Suppressor cells in tuberculosis. J. Immunol. 121:2573-2579.
19. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, M. Shepard, and M. A. Palladino. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571-576.
20. Gajewski, T. F., and F. W. Fitch. 1988. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245-4252.
21. Galdiero, F., G. Cipollaro de L'Ero, N. Benedetto, M. Galdiero, and M. A. Tufano. 1993. Release of cytokines induced by Salmonella lyphimurium porins. Infect. Immun. 61:155-161.
22. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000.
23. Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci. 1986. Transforming growth factor-β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
24. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alverez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
25. Lee, H. M., and S. Rich. 1991. Costimulation of T cell proliferation by transforming growth factor-β1. J. Immunol. 147:1127-1133.
26. Lowrance, J. H., F. X. O'Sullivan, T. E. Caver, W. Waegell, and H. D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defence against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
28. Nakane, A., M. Asano, S. Sasaki, S. Nishikawa, T. Miura, M. Kohanawa, and T. Minagawa. 1996. Transforming growth factor β is protective in host resistance against Listeria monocytogenes infection in mice. Infect. Immun. 64:3901-3904.
29. + T cells. J. Immunol. 155:609-618.
30. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
31. + T cells. Annu. Rev. Immunol. 12:635-673.
32. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652-1656.
33. Shalaby, M. R., and A. J. Amman. 1988. Suppression of immune cell function in vitro by recombinant human transforming growth factor β. Cell. Immunol. 112:343-350.
34. Silva, J. S., D. R. Twardizik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor-β (TGF-β). J. Exp. Med. 172:1774-1777.
35. 1 is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155:1349-1360.
36. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper-cell subset phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115-144.
37. Toossi, Z., J. P. Lapurga, R. J. Ondash, J. R. Sedor, and J. J. Ellner. 1990. Expression of functional interleukin-2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J. Clin. Invest. 85: 1777-1784.
38. Van der Meer, J. W. M., M. Helle, and A. Aarden. 1989. Comparison of the effects of recombinant interleukin-6 and recombinant interleukin-1 on non-specific resistance to infection. Eur. J. Immunol. 19:413-416.
39. Van Obberghen-Schilling, E., N. S. Roche, K. C. Flanders, M. Sporn, and A. Roberts. 1988. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263:7741-7746.
40. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-5792.
41. Wahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts, and M. B. Sporn. 1988. Transforming growth factor-β is a potent immunosuppressive agent which inhibits interleukin-1 dependent lymphocyte proliferation. J. Immunol. 140:3026-3032.
42. Welch, G. R., M. L. Wong, and S. M. Wahl. 1990. Selective induction of FcγRIII on human monocytes by TGF-β. J. Immunol. 144:3444-3448.
43. - cells that make Th2 cytokines and help B cells. Science 260:1802-1805.